Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation

被引:0
|
作者
Mónica Acevedo
Ramón Corbalán
Sandra Braun
Jaime Pereira
Ilse González
Carlos Navarrete
机构
[1] Pontificia Universidad Católica de Chile,Facultad de Medicina, División de Enfermedades Cardiovasculares
[2] Pontificia Universidad Católica de Chile,Facultad de Medicina, Departamento de Hematología
[3] Universidad de la Serena,Departamento de Matemáticas
来源
Journal of Thrombosis and Thrombolysis | 2012年 / 33卷
关键词
Atrial fibrillation; C-reactive protein; Soluble thrombomodulin; Cardiac biomarkers; Cardiac rhythm;
D O I
暂无
中图分类号
学科分类号
摘要
C-reactive protein (CRP) is increased in patients with atrial fibrillation (AF) and it might predict the lack of sinus rhythm maintenance in the long term follow-up. Scarce data have been reported relating endothelial dysfunction and/or haemostatic or platelet markers to sinus rhythm maintenance in AF patients. We aimed to determine whether some biochemical markers including soluble thrombomodulin (sTM), soluble P-selectin, thrombin–antithrombin (TAT) complex and CRP levels could predict sinus rhythm maintenance at 1 year follow-up in non-valvular AF patients. 130 patients (70 males, mean age 67 ± 13 years) with newly diagnosed AF naïve of antithrombotic or antiplatelet therapy were studied. Baseline CRP, P-selectin, sTM and TAT levels were compared to those of 20 matched-healthy subjects in sinus rhythm. AF patients had significantly higher plasma CRP (10.5 ± 2.2 vs 3.25 ± 0.3 mg/l, p = 0.001), P-selectin (219 ± 141 vs 126 ng/ml, p = 0.01), and TAT (54 ± 237 vs 2.7 ± 3.3 ng/l, p = 0.001) levels compared with controls. Soluble TM levels, although higher than controls, did not reach statistical significance. Multivariate regression analyses showed that elevated CRP (OR = 4.8, p = 0.02) and sTM (OR = 1.05, p = 0.04) were the only two predictors of lack of sinus rhythm at 1 year follow-up. An altered inflammatory, haemostatic, endothelial and platelet environment exists in newly diagnosed AF patients. CRP and sTM levels might be used as biochemical markers to predict the status of cardiac rhythm at 1 year follow-up in some AF patients.
引用
收藏
页码:383 / 388
页数:5
相关论文
共 50 条
  • [41] Economic evaluation of dabigatran for stroke prevention in patients with non-valvular atrial fibrillation
    Miguel, Luis Silva
    Rocha, Evangelista
    Ferreira, Jorge
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2013, 32 (7-8) : 557 - 565
  • [42] Impact of Frailty in Non-Valvular Atrial Fibrillation Elderly Patients on Anticoagulation Therapy
    Matsui, Kunihiko
    Kusano, Kengo F.
    Akao, Masaharu
    Tsuji, Hikari
    Hiramitsu, Shinya
    Hatori, Yutaka
    Odakura, Hironori
    Ogawa, Hisao
    CIRCULATION, 2023, 148
  • [43] Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation
    Wess, Mark L.
    Schauer, Daniel P.
    Johnston, Joseph A.
    Moomaw, Charles J.
    Brewer, David E.
    Cook, E. Francis
    Eckman, Mark H.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (04) : 411 - 417
  • [44] Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
    Novikova, Nina A.
    Volovchenko, Alexey N.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (05) : 590 - 594
  • [45] Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study
    Xiang, Wei
    Zhang, Jingwei
    Liu, Meilin
    Liu, Fang
    Feng, Xueru
    Wang, Yuchuan
    CLINICAL INTERVENTIONS IN AGING, 2015, 10 : 515 - 519
  • [46] Efficacy and safety of rivaroxaban for secondary prevention in non-valvular atrial fibrillation after cardioembolic stroke complicated by hemorrhagic transformation: a case report with a 3-year follow-up
    Giubilato, Simona
    Giordano, Guido
    Scarabelli, Marilena
    Amico, Francesco
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2020, 179 (7-8) : 474 - 478
  • [47] Mean corpuscular volume and red cell distribution width as predictors of left atrial stasis in patients with non-valvular atrial fibrillation
    Providencia, Rui
    Ferreira, Maria Joao
    Goncalves, Lino
    Faustino, Ana
    Paiva, Luis
    Fernandes, Andreia
    Barra, Sergio
    Pimenta, Joana
    Leitao-Marques, Antonio M.
    AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2013, 3 (02): : 91 - 102
  • [48] Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation
    Song, Ting
    Xin, Xiao
    Cui, Peirong
    Zong, Mingcan
    Li, Xianhua
    PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 493 - 500
  • [49] Effect of Polypharmacy on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation
    Yamashita, Takeshi
    Akao, Masaharu
    Atarashi, Hirotsugu
    Ikeda, Takanori
    Koretsune, Yukihiro
    Okumura, Ken
    Shimizu, Wataru
    Suzuki, Shinya
    Tsutsui, Hiroyuki
    Toyoda, Kazunori
    Hirayama, Atsushi
    Yasaka, Masahiro
    Yamaguchi, Takenori
    Teramukai, Satoshi
    Kimura, Tetsuya
    Morishima, Yoshiyuki
    Takita, Atsushi
    Inoue, Hiroshi
    CIRCULATION JOURNAL, 2023, 87 (01) : 6 - +
  • [50] Characteristics of Pulmonary Vein Enlargement in Non-Valvular Atrial Fibrillation Patients with Stroke
    Lee, Jung Myung
    Kim, Jong-Youn
    Shim, Jaemin
    Uhm, Jae-Sun
    Kim, Young Jin
    Lee, Hye-Jeong
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Joung, Boyoung
    YONSEI MEDICAL JOURNAL, 2014, 55 (06) : 1516 - 1525